pubmed-article:15510979 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C0677929 | lld:lifeskim |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C1518527 | lld:lifeskim |
pubmed-article:15510979 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
pubmed-article:15510979 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15510979 | pubmed:dateCreated | 2004-10-29 | lld:pubmed |
pubmed-article:15510979 | pubmed:abstractText | The aim of this study was to investigate the efficacy of postoperative locoregional radiotherapy in patients with T1-T2 breast cancer and four or more positive axillary lymph nodes submitted to mastectomy or breast-conserving surgery followed by standard-dose or high-dose adjuvant chemotherapy. The incidence of locoregional relapses and the survival correlated with the number of positive nodes were recorded for each treatment arm. | lld:pubmed |
pubmed-article:15510979 | pubmed:language | eng | lld:pubmed |
pubmed-article:15510979 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15510979 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15510979 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15510979 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15510979 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15510979 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15510979 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15510979 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15510979 | pubmed:issn | 0300-8916 | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:LatiniPaoloP | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:De... | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:GoriStefaniaS | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:AnselmoPaolaP | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:AristeiCynthi... | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:PerrucciElisa... | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:MascioniFranc... | lld:pubmed |
pubmed-article:15510979 | pubmed:author | pubmed-author:FrattegianiAl... | lld:pubmed |
pubmed-article:15510979 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15510979 | pubmed:volume | 90 | lld:pubmed |
pubmed-article:15510979 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15510979 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15510979 | pubmed:pagination | 379-86 | lld:pubmed |
pubmed-article:15510979 | pubmed:dateRevised | 2008-12-12 | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:meshHeading | pubmed-meshheading:15510979... | lld:pubmed |
pubmed-article:15510979 | pubmed:articleTitle | T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study. | lld:pubmed |
pubmed-article:15510979 | pubmed:affiliation | Radiotherapy Oncology, Policlinico Hospital and University of Perugia, Italy. teresa.perrucci@tiscalinet.it | lld:pubmed |
pubmed-article:15510979 | pubmed:publicationType | Journal Article | lld:pubmed |